Blog

FDA – Safety Report

FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering

FDA Drug Safety Communication

A safety announcement by the FDA on the dangers of rapid discontinuation of opioid medication with patients who are physically dependent.

Read the article here.

Upcoming

Please join us for an upcoming M&M style meeting where members will present details of difficult cases to a peer committee and receive feedback. These meetings are held every 4 months at Swedish Edmonds Hospital. Join our email list to receive event details or contact us to learn more.